Detalhe da pesquisa
1.
Translational assessment of a DATA-functionalized FAP inhibitor with facile 68Ga-labeling at room temperature.
Eur J Nucl Med Mol Imaging
; 50(11): 3202-3213, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37284857
2.
Highlights of the 32th Annual Congress of the EANM, Barcelona 2019: the nucleolympic games of nuclear medicine-a global competition for excellence.
Eur J Nucl Med Mol Imaging
; 47(8): 1808-1819, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32409894
3.
First-in-human dosimetry of gastrin-releasing peptide receptor antagonist [177Lu]Lu-RM2: a radiopharmaceutical for the treatment of metastatic castration-resistant prostate cancer.
Eur J Nucl Med Mol Imaging
; 47(1): 123-135, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31482426
4.
FDG PET Hybrid Imaging.
Recent Results Cancer Res
; 216: 625-667, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32594401
5.
CDK4/6 Inhibition Controls Proliferation of Bladder Cancer and Transcription of RB1.
J Urol
; 195(3): 771-9, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26318986
6.
Prospective evaluation of [11C]Choline PET/CT in therapy response assessment of standardized docetaxel first-line chemotherapy in patients with advanced castration refractory prostate cancer.
Eur J Nucl Med Mol Imaging
; 43(12): 2105-2113, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27317482
7.
Patient-Orientated Evaluation of Treatment of Non-Melanoma Skin Cancer with Rhenium-188 Compared to Surgery.
Healthcare (Basel)
; 12(9)2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38727478
8.
Topical 188Re Ionizing Radiation Therapy Exerts High Efficacy in Curing Nonmelanoma Skin Cancer.
Clin Nucl Med
; 48(10): 869-876, 2023 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37682602
9.
Presurgical 68Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging Trial.
Eur Urol
; 84(6): 588-596, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37482512
10.
68Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment: An International Multicenter Prospective Study.
J Nucl Med
; 64(7): 1043-1048, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37230530
11.
Streamlined Schemes for Dosimetry of 177Lu-Labeled PSMA Targeting Radioligands in Therapy of Prostate Cancer.
Cancers (Basel)
; 13(15)2021 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34359784
12.
Evaluation of [68Ga]Ga-PSMA PET/CT for therapy response assessment of [177Lu]Lu-PSMA radioligand therapy in metastasized castration refractory prostate cancer and correlation with survival.
Nucl Med Commun
; 42(11): 1217-1226, 2021 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34424870
13.
Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging Trial.
JAMA Oncol
; 7(11): 1635-1642, 2021 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34529005
14.
Anatomical MRI and [18F]FDG PET/CT imaging of Schistosoma mansoni in a NMRI mouse model.
Sci Rep
; 10(1): 17343, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33060721
15.
[18F]FDG PET/CT for assessing inguinal lymph nodes in patients with penile cancer - correlation with histopathology after inguinal lymphadenectomy.
Nuklearmedizin
; 57(1): 26-30, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29536497
16.
Peptide receptor radionuclide therapy with 177Lu-DOTA-octreotate: dosimetry, nephrotoxicity, and the effect of hematological toxicity on survival.
Nucl Med Commun
; 39(3): 236-246, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29315138
17.
Wntless promotes bladder cancer growth and acts synergistically as a molecular target in combination with cisplatin.
Urol Oncol
; 35(9): 544.e1-544.e10, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28501564
18.
[68Ga]pentixafor for CXCR4 imaging in a PC-3 prostate cancer xenograft model - comparison with [18F]FDG PET/CT, MRI and ex vivo receptor expression.
Oncotarget
; 8(56): 95606-95619, 2017 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29221153
19.
Evaluation of Prostate Cancer with 11C- and 18F-Choline PET/CT: Diagnosis and Initial Staging.
J Nucl Med
; 57(Suppl 3): 38S-42S, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27694169
20.
Non-invasive assessment of inter-and intrapatient variability of integrin expression in metastasized prostate cancer by PET.
Oncotarget
; 7(19): 28151-9, 2016 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27058620